Immune persistence after pertussis vaccination

Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence

(2016) Katie L. Sealey et al.   INFECTION GENETICS AND EVOLUTION

Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years

(2016) Zhiyun Chen et al.   JOURNAL OF INFECTION

Pertussis specific cell-mediated immune responses ten years after acellular pertussis booster vaccination in young adults

(2016) Kirsi Gröndahl-Yli-Hannuksela et al.   VACCINE

The predicted persistence and kinetics of antibody decline 9 years after pre-school booster vaccination in UK children

(2016) Merryn Voysey et al.   VACCINE

Pertussis vaccination during pregnancy: Antibody persistence in infants

(2016) Alba Vilajeliu et al.   VACCINE

Pertussis vaccination during pregnancy in Vietnam: Results of a randomized controlled trial Pertussis vaccination during pregnancy

(2016) Ha Thi Thu Hoang et al.   VACCINE

Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity

(2016) Tami H. Skoff et al.   JAMA Pediatrics

Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013

(2016) Ulrich Heininger et al.   PLoS One

Is Pertussis Infection Neglected in China? Evidence from a Seroepidemiology Survey in Zhejiang, an Eastern Province of China

(2016) Hanqing He et al.   PLoS One

Adult pertussis is unrecognized public health problem in Thailand

(2015) Nirada Siriyakorn et al.   BMC INFECTIOUS DISEASES

Pertussis may be the cause of prolonged cough in adolescents and adults in the interepidemic period

(2015) Analíria Moraes Pimentel et al.   Brazilian Journal of Infectious Diseases

Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis

(2015) Jason M. Warfel et al.   Clinical and Vaccine Immunology

Identification of Pertussis-Specific Effector Memory T Cells in Preschool Children

(2015) Lia de Rond et al.   Clinical and Vaccine Immunology

Antibody Responses After Primary Immunization in Infants Born to Women Receiving a Pertussis-containing Vaccine During Pregnancy: Single Arm Observational Study With a Historical Comparator

(2015) Shamez N. Ladhani et al.   CLINICAL INFECTIOUS DISEASES

Pertussis vaccines and the challenge of inducing durable immunity

(2015) Jason M Warfel et al.   CURRENT OPINION IN IMMUNOLOGY

Under-recognized pertussis in adults from Asian countries: a cross-sectional seroprevalence study in Malaysia, Taiwan and Thailand

(2015) M. T. KOH et al.   EPIDEMIOLOGY AND INFECTION

The Decline of Pertussis-Specific Antibodies After Tetanus, Diphtheria, and Acellular Pertussis Immunization in Late Pregnancy

(2015) Bahaa Abu Raya et al.   JOURNAL OF INFECTIOUS DISEASES

Seroprevalence of Pertussis in The Gambia

(2015) Susana Scott et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Duration of Pertussis Immunity After DTaP Immunization: A Meta-analysis

(2015) A. McGirr et al.   PEDIATRICS

Tdap Vaccine Effectiveness in Adolescents During the 2012 Washington State Pertussis Epidemic

(2015) A. M. Acosta et al.   PEDIATRICS

Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14–15 years

(2015) R.M. Carlsson et al.   VACCINE

Immunogenicity of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine compared to standard-dose diphtheria, tetanus, acellular pertussis when used as a pre-school booster in UK children: A 5-year follow-up of a randomised controlled study

(2015) T. John et al.   VACCINE

A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine

(2015) Shashank Dalvi et al.   Human Vaccines & Immunotherapeutics

Seroepidemiology of diphtheria and pertussis in Beijing, China: A cross-sectional study

(2015) Xiaomei Li et al.   Human Vaccines & Immunotherapeutics

A Change in Vaccine Efficacy and Duration of Protection Explains Recent Rises in Pertussis Incidence in the United States

(2015) Manoj Gambhir et al.   PLoS Computational Biology

Seroprevalence studies of pertussis: what have we learned from different immunized populations

(2015) Alex-Mikael Barkoff et al.   Pathogens and Disease

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose

(2015) Jennifer Liang et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Serodiagnosis as Adjunct Assay for Pertussis Infection in São Paulo, Brazil

(2014) Lourdes R. A. Vaz-de-Lima et al.   Clinical and Vaccine Immunology

Immunogenicity, Safety, and Antibody Persistence at 3, 5, and 10 Years Postvaccination in Adolescents Randomized to Booster Immunization with a Combined Tetanus, Diphtheria, 5-Component Acellular Pertussis, and Inactivated Poliomyelitis Vaccine Administered with a Hepatitis B Virus Vaccine Concurrently or 1 Month Apart

(2014) Joanne Embree et al.   Clinical and Vaccine Immunology

A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012-2013

(2014) G. Dabrera et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of pertussis in adolescents and adults in Turkey

(2014) A. KARAGUL et al.   EPIDEMIOLOGY AND INFECTION

Decline of IgG pertussis toxin measured in umbilical cord blood, and neonatal and early infant serum

(2014) L. C. S. Smallenburg et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Pertussis in Latin America: epidemiology and control strategies

(2014) Luiza Helena Falleiros Arlant et al.   Expert Review of Anti-Infective Therapy

Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology

(2014) Sarah L Sheridan et al.   Expert Review of Vaccines

Effectiveness and cost-effectiveness of different immunization strategies against whooping cough to reduce child morbidity and mortality

(2014) Amado Rivero-Santana et al.   HEALTH POLICY

Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years — India, 2014 and updates on immunization

(2014) Vipin M. Vashishtha et al.   INDIAN PEDIATRICS

Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants

(2014) Flor M. Munoz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) for Preventing Pertussis: Evidence of Rapidly Waning Immunity and Difference in Effectiveness by Tdap Brand

(2014) Ruth Koepke et al.   JOURNAL OF INFECTIOUS DISEASES

Pertussis Resurgence: Perspectives From the Working Group Meeting on Pertussis on the Causes, Possible Paths Forward, and Gaps in Our Knowledge

(2014) D. L. Burns et al.   JOURNAL OF INFECTIOUS DISEASES

Pertussis Serosurveillance Study in Izmir, Turkey

(2014) E. Turkoglu et al.   JOURNAL OF TROPICAL PEDIATRICS

Effectiveness of maternal pertussis vaccination in England: an observational study

(2014) Gayatri Amirthalingam et al.   LANCET

Pertussis vaccine in pregnancy—first dose for every infant?

(2014) Peter B McIntyre et al.   LANCET

Prevalence of asymptomatic Bordetella pertussis and Bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: A cross-sectional study

(2014) Qi Zhang et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels – A prospective study

(2014) Bahaa Abu Raya et al.   VACCINE

Humoral and B-cell memory responses in children five years after pertussis acellular vaccine priming

(2014) Maria Carollo et al.   VACCINE

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?

(2014) C. M. Ausiello et al.   mBio

Differential T- and B-Cell Responses to Pertussis in Acellular Vaccine-Primed versus Whole-Cell Vaccine-Primed Children 2 Years after Preschool Acellular Booster Vaccination

(2013) Rose-Minke Schure et al.   Clinical and Vaccine Immunology

Bordetella pertussis seroprevalence in Belgian adults aged 20–39 years, 2012

(2013) K. HUYGEN et al.   EPIDEMIOLOGY AND INFECTION

Seroprevalence of Bordetella pertussis in the Mexican population: a cross-sectional study

(2013) C. CONDE-GLEZ et al.   EPIDEMIOLOGY AND INFECTION

Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin

(2013) F. R. MOOI et al.   EPIDEMIOLOGY AND INFECTION

Priming with Whole-Cell versus Acellular Pertussis Vaccine

(2013) Juventila Liko et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pregnancy Dose Tdap and Postpartum Cocooning to Prevent Infant Pertussis: A Decision Analysis

(2013) A. Terranella et al.   PEDIATRICS

Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers

(2013) N. P. Klein et al.   PEDIATRICS

Waning Immunity to Pertussis Following 5 Doses of DTaP

(2013) S. Y. Tartof et al.   PEDIATRICS

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

(2013) J. M. Warfel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: Comparison of three different vaccines and effect of a booster dose

(2013) Françoise Vermeulen et al.   VACCINE

Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination

(2013) Kaatje Smits et al.   VACCINE

Early Impact of the US Tdap Vaccination Program on Pertussis Trends

(2012) Amanda C. Cohn   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Age-Related Differences in Patterns of Increased Bordetella pertussis Antibodies

(2012) Harry E. Prince et al.   Clinical and Vaccine Immunology

Importance of Timing of Maternal Combined Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Immunization and Protection of Young Infants

(2012) C. Mary Healy et al.   CLINICAL INFECTIOUS DISEASES

Nomenclature for Immune Correlates of Protection After Vaccination

(2012) S. A. Plotkin et al.   CLINICAL INFECTIOUS DISEASES

Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American Outbreak

(2012) Maxwell A. Witt et al.   CLINICAL INFECTIOUS DISEASES

Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®)

(2012) Paul L. McCormack   DRUGS

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

(2012) Sarah L. Sheridan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010

(2012) Lara K. Misegades et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Immunity to the respiratory pathogen Bordetella pertussis

(2012) R Higgs et al.   Mucosal Immunology

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

(2012) Nicola P. Klein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine

(2012) A. Tomovici et al.   VACCINE

Sources of pertussis infection in young infants: A review of key evidence informing targeting of the cocoon strategy

(2012) K.E. Wiley et al.   VACCINE

Pertussis: A Review of Disease Epidemiology Worldwide and in Italy

(2012) Giovanni Gabutti et al.   International Journal of Environmental Research and Public Health

Maternal immunization with tetanus–diphtheria–pertussis vaccine: effect on maternal and neonatal serum antibody levels

(2011) Stanley A. Gall et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

A DTaP–IPV//PRP∼T vaccine (Pentaxim™): a review of 16 years’ clinical experience

(2011) Stanley A Plotkin et al.   Expert Review of Vaccines

Bordetella Pertussis IgG and IgA Antibodies Seroprevalence Among 1–35 y-old Population: The Role of Subclinical Pertussis Infection

(2011) Mohammed-Jafar Saffar et al.   INDIAN JOURNAL OF PEDIATRICS

Rationale for pertussis booster vaccination throughout life in Europe

(2011) Fred Zepp et al.   LANCET INFECTIOUS DISEASES

Effect of a Prepregnancy Pertussis Booster Dose on Maternal Antibody Titers in Young Infants

(2011) Elke Leuridan et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Safety and Immunogenicity of 2 Mixed Primary Infant Immunization Schedules of Pentavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliomyelitis, and Haemophilus influenzae Type b Vaccines at 2, 4, and 6 Months of Age

(2011) Joanne M. Langley et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Induction of Bordetella pertussis-specific immune memory by DTPa vaccines

(2011) Sandra Morel et al.   VACCINE

Effectiveness of Adolescent and Adult Tetanus, Reduced‐Dose Diphtheria, and Acellular Pertussis Vaccine against Pertussis

(2010) Stanley C. Wei et al.   CLINICAL INFECTIOUS DISEASES

Decennial Administration of a Reduced Antigen Content Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Young Adults

(2010) Jussi Mertsola et al.   CLINICAL INFECTIOUS DISEASES

Pertussis Disease Burden in the Household: How to Protect Young Infants

(2010) S. C. de Greeff et al.   CLINICAL INFECTIOUS DISEASES

A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults

(2010) Robert Booy et al.   VACCINE

Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins

(2010) Lotte H. Hendrikx et al.   VACCINE

Seroprevalence of Immunoglobulin G antibodies against pertussis toxin among asymptomatic medical students in the west of Iran: a cross sectional study

(2009) Seyyed Hamid Hashemi et al.   BMC INFECTIOUS DISEASES

PERTUSSIS VACCINE EFFECTIVENESS AFTER MASS IMMUNIZATION OF HIGH SCHOOL STUDENTS IN AUSTRALIA

(2009) Claudia Rank et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: Effect of vaccine antigen content

(2009) Lotte H. Hendrikx et al.   VACCINE

Estimating the Duration of Pertussis Immunity Using Epidemiological Signatures

(2009) Helen J. Wearing et al.   PLoS Pathogens

Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine

(2008) M. Riffelmann et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data

(2008) F. Bailleux et al.   VACCINE

Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination

(2008) Nikolaus Rieber et al.   VACCINE